ALL HANDS ON DECK

A Focus on Current and Emerging Treatment Options in the Frontline Setting for Peripheral T-cell Lymphoma

Activity Description

Peripheral T-cell lymphomas (PTCLs) are a diverse collection of non-Hodgkin lymphomas that make treatment and patient-centered care challenging and highlight the need for targeted therapies based on molecular and genetic profiling to enhance treatment efficacy and reduce treatment-related adverse events (TRAEs). The role of CD30 expression further complicates patient care, because its variable expression among PTCL subtypes prevents establishing a uniform treatment approach. Though randomized clinical trial data is limited, these data can help refine treatment protocols and reduce the risk of relapse by identifying patients who may benefit from maintenance therapies or alternative treatment approaches.

In this CEC Oncology Grand Rounds series, expert faculty will evaluate the efficacy and safety of first-line PTCL treatments; explore the diagnostic, prognostic, and therapeutic applications of CD30 expression in PTCL subtypes; and discuss strategies to expand collaborative learning and communication that can enhance clinician understanding and proficiency in making informed therapeutic decisions as a treatment team.

Target Audience

Academic and community-based hematologist/oncologists, oncology nurses, oncology nurse practitioners (NPs), and physician associates (PAs)

Learning Objectives

At the conclusion of this activity, learners will be able to better:

  • Evaluate long-term efficacy and safety of first-line peripheral T-cell lymphoma (PTCL) treatments
  • Identify the diagnostic, prognostic, and therapeutic applications of CD30 expression in PTCL subtypes
  • Implement multidisciplinary strategies to enhance patient outcomes and therapeutic decision-making in PTCL
Activity Chairs
faculty_HorwitzS

Steven Horwitz, MD (Chair)

Nonna’s Garden Foundation Chair

Member and Attending Physician at Memorial Sloan Kettering Cancer Center

Professor of Medicine, Weill Cornell Medical College

New York, New York

faculty_ZitellaL

Laura J. Zitella, MS, RN, ANP-BC, AOCN (Co-Chair)

Nurse Practitioner

Hematology, Blood & Marrow Transplant, and Cellular Therapies (HBC) Program

UCSF Helen Diller Family Comprehensive Cancer Center

Associate Clinical Professor, School of Nursing

University of California–San Francisco

San Francisco, California

Book a Live or Virtual Grand Rounds Today!
Available November 2024–February 2025
Credit Information
JA_Commendation_Mark_edit2-1

Jointly Accredited Provider
In support of improving patient care, Creative Educational Concepts, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

IPCE_Credit_Logo_012017

IPCE
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education Credit for learning and change.

Physicians (ACCME)
Creative Educational Concepts, LLC, designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC)
This activity is designated for 1.0 contact hours.

Oncology Nursing Certification (ONCC)
This activity is designated for 1.0 contact hours. The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points in the following ILNA subject areas:

OCN® 

  • Care Continuum

  • Oncologic Emergencies

  • Oncology Nursing Practice

  • Psychosocial Dimensions of Care

  • Symptom Management, Palliative Care, Supportive Care

  • Treatment

BMTCN®

  • Care Continuum

  • Professional Practice/Performance

CBCN® 

  • Care Continuum 
  • Psychosocial Dimensions of Care
  • Treatment

AOCNP®

  • Care Continuum

  • Oncologic Emergencies

  • Professional Practice/Performance

  • Psychosocial Dimensions of Care

  • Roles of the APRN

  • Symptom Management, Palliative Care, Supportive Care

  • Treatment

CPHON® 

  • Care Continuum
  • Oncologic Emergencies

  • Symptom Management, Palliative Care, Supportive Care

  • Treatment

PAs (AAPA)
Creative Educational Concepts, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

RCP Canada
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For more information, contact Ashley Lilly at lillya@ceconcepts.com
Presented by Creative Educational Concepts LLC.
This program is supported by an independent educational grant from Pfizer Inc.